|
|
|
Insider
Information: |
Sharp Shalini |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
215,117 |
|
Indirect Shares
|
104,270 |
|
|
Direct
Value |
$4,582,529 |
|
|
Indirect Value
|
$46,244 |
|
|
Total
Shares |
319,387 |
|
|
Total
Value |
$4,628,773 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
6
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
5.0
|
Percentage
Gain/Loss : |
0.0%
|
537.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Agenus Inc |
AGEN |
Director |
2013-01-30 |
81,311 |
2015-09-28 |
104,270 |
Premium* |
|
Ultragenyx Pharmaceutical Inc |
RARE |
EVP, Finance |
2020-10-14 |
97,812 |
|
0 |
Premium* |
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
35,000 |
2021-02-10 |
0 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
|
2024-01-23 |
0 |
2021-03-26 |
0 |
Premium* |
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-05-17 |
994 |
2024-05-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
130 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AGEN |
Agenus Inc |
Director |
|
2012-08-29 |
4 |
AS |
$4.64 |
$1,336 |
D/D |
(288) |
76,602 |
0 |
- |
|
AGEN |
Agenus Inc |
Director |
|
2012-07-26 |
4 |
A |
$4.61 |
$2,881 |
D/D |
625 |
76,890 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
See RemarksOfficer |
|
2014-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
79,755 |
|
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Senior Vice President |
|
2014-08-18 |
4 |
AS |
$53.97 |
$215,880 |
D/D |
(4,000) |
80,255 |
0 |
- |
|
AGEN |
Agenus Inc |
Director |
|
2012-06-20 |
4 |
D |
$4.92 |
$10,913 |
D/D |
(2,218) |
80,372 |
0 |
- |
|
AGEN |
Agenus Inc |
Director |
|
2012-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
4,035 |
80,637 |
0 |
- |
|
AGEN |
Agenus Inc |
Director |
|
2012-10-31 |
4 |
AS |
$4.40 |
$1,267 |
D/D |
(288) |
80,974 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2019-03-18 |
4/A |
OE |
$6.86 |
$82,320 |
D/D |
12,000 |
81,126 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2019-03-18 |
4 |
OE |
$6.86 |
$82,320 |
D/D |
12,000 |
81,157 |
0 |
- |
|
AGEN |
Agenus Inc |
Director |
|
2012-10-26 |
4 |
A |
$4.42 |
$2,763 |
D/D |
625 |
81,262 |
0 |
- |
|
AGEN |
Agenus Inc |
Director |
|
2013-01-30 |
4 |
AS |
$4.36 |
$1,256 |
D/D |
(288) |
81,311 |
0 |
- |
|
AGEN |
Agenus Inc |
Director |
|
2013-01-28 |
4 |
A |
$4.35 |
$2,719 |
D/D |
625 |
81,599 |
0 |
- |
|
AGEN |
Agenus Inc |
Director |
|
2012-06-19 |
4 |
A |
$5.26 |
$66,870 |
D/D |
12,713 |
82,590 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Senior Vice President |
|
2014-01-30 |
4 |
B |
$21.00 |
$94,500 |
D/D |
4,500 |
84,255 |
2.74 |
- |
|
AGEN |
Agenus Inc |
CFO |
|
2009-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
26,201 |
90,091 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP, Finance |
|
2020-10-14 |
4 |
S |
$87.99 |
$32,996 |
D/D |
(375) |
97,812 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2020-08-17 |
4 |
S |
$88.24 |
$1,271,073 |
D/D |
(14,378) |
98,187 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2019-09-16 |
4 |
OE |
$0.81 |
$176,317 |
D/D |
31,843 |
99,089 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2019-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,434 |
100,523 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2020-05-18 |
4 |
S |
$73.29 |
$1,612,260 |
D/D |
(21,985) |
100,944 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2020-06-01 |
4 |
D |
$69.38 |
$24,144 |
D/D |
(348) |
101,208 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2020-06-03 |
4 |
S |
$74.23 |
$759,670 |
D/D |
(10,234) |
101,208 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2020-06-04 |
4 |
S |
$74.01 |
$189,762 |
D/D |
(2,564) |
101,208 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2020-05-19 |
4 |
S |
$73.32 |
$522,625 |
D/D |
(7,128) |
101,556 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2020-08-17 |
4 |
OE |
$48.43 |
$698,524 |
D/D |
11,357 |
101,856 |
0 |
- |
|
130 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|